CARFILZOMIB vs CASPOFUNGIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CARFILZOMIB vs CASPOFUNGIN: Safety Overview
| Metric | CARFILZOMIB | CASPOFUNGIN |
|---|---|---|
| Total FAERS Reports | 21,814 | 3,814 |
| Deaths Reported | 3,448 | 1,419 |
| Death Rate | 15.8% | 37.2% |
| Hospitalizations | 7,502 | 1,638 |
| Average Patient Age | 64.7 yrs | 47.5 yrs |
| % Female Patients | 42.6% | 42.8% |
| FDA Approval Date | Jul 20, 2012 | Dec 30, 2016 |
| Manufacturer | Onyx Pharmaceuticals, Inc. | Sandoz Inc |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |